NCT00233597View on ClinicalTrials.gov

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

March 31, 2007

Conditions
Anemia
Interventions
DRUG

ferumoxytol or oral iron

Trial Locations (50)

10016

New York

10128

New York

11203

Brooklyn

11212

Brooklyn

11238

Brooklyn

11355

Flushing

11413

Springfield Gardens

11501

Mineola

14127

Orchard Park

17044

Lewistown

20814

Bethesda

22030

Fairfax

22304

Alexandria

23320

Chesapeake

23507

Norfolk

24153

Salem

27599

Chapel Hill

29150

Sumter

29605

Greenville

30901

Augusta

33614

Tampa

34667

Hudson

37923

Knoxville

38104

Memphis

39216

Jackson

39705

Columbus

48202

Detroit

48236

Detroit

54911

Appleton

60081

Gurnee

60141

Hines

63110

St Louis

64111

Kansas City

70809

Baton Rouge

75216

Dallas

75240

Dallas

77099

Houston

78411

Corpus Christi

78758

Austin

85012

Phoenix

85284

Tempe

87131

Albuquerque

90073

Los Angeles

94014

Mountain View

96817

Honolulu

97213

Portland

99204

Spokane

06511

New Haven

02135

Boston

01107

Springfield

Sponsors
All Listed Sponsors
lead

AMAG Pharmaceuticals, Inc.

INDUSTRY